Literature DB >> 6141677

Mechanism of nitrate-induced vasodilation and tolerance.

W R Kukovetz, S Holzmann.   

Abstract

Various NO-forming compounds have in common that along with their mechanically relaxing effect, they increase the concentration of cyclic 3'5'-guanosine monophosphate (cGMP) in vascular smooth muscle. This has been shown for nitroglycerin, NaNO2, nitroprusside-Na, 2'3'-dinitroadenosine-5'-ethylcarboxamide (B-744-99), and more recently for SIN-1, the vasoactive metabolite of molsidomine, and for nicorandil (SG-75). In isolated circular strips of bovine coronary arteries, suspended in a partially depolarizing Tyrode's solution containing 27 mM K+, these drugs produced dose-dependent relaxations which were slightly preceded by concomitant increases in cGMP levels, measured at various moments of drug action by freeze-clamping the strips, and by subsequent determinations of cyclic nucleotide levels by RIA. Levels of cyclic 3',5'-AMP were not significantly changed, except by B-744-99. Inhibition of cGMP hydrolysis by the addition of M & B 22,948 (2-o-propoxyphenyl-8-azapurin-6-one) augmented the nitrate-induced rises in cGMP as well as their relaxing effects on coronary arterial strips. In the presence of the vital stain methylene blue - which was shown in vitro to prevent nitrate-induced activation of guanylate cyclase, the enzyme which forms cGMP from GTP - the relaxant actions as well as the increases in cGMP produced by several of these nitro-compounds in coronary strips were almost abolished. The actions of organic nitrates appear to depend on their previous reduction to NO by a rate-limiting step involving cysteine, whereas those of nitroprusside and SIN-1 are probably independent of cysteine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6141677

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  13 in total

1.  Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo.

Authors:  S Moncada; D D Rees; R Schulz; R M Palmer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

Review 2.  Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.

Authors:  S Silber
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  The haemodynamic and anti-ischaemic effects of a single tablet of 80 mg isosorbide dinitrate in slow-release formulation and a review of nitrate tolerance.

Authors:  S Silber; A C Vogler; K H Krause; K Theisen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Nitroglycerin-induced desensitization of vascular smooth muscle may be mediated through cyclic GMP-disinhibition of phosphatidylinositol hydrolysis.

Authors:  J K Chuprun; R M Rapoport
Journal:  Experientia       Date:  1987-03-15

Review 5.  Endogenous and exogenous nitrates and their role in myocardial ischaemia.

Authors:  T F Lüscher
Journal:  Br J Clin Pharmacol       Date:  1992       Impact factor: 4.335

6.  Nitroglycerin-induced relaxation of anorectal smooth muscle: evidence for apparent lack of tolerance development in the anaesthetized rat.

Authors:  E Q Wang; D M Soda; H L Fung
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

Review 7.  Pharmacology and therapeutic effects of nicorandil.

Authors:  M Kinoshita; K Sakai
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 8.  Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates.

Authors:  U Thadani; T Whitsett
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

9.  Effect of the molsidomine metabolite SIN-1 on coronary arteries and peripheral vessels of sheep with special reference to tolerance and endothelium.

Authors:  M H Yousif; F Yousif; O Thulesius
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

Review 10.  Short and long-acting oral nitrates for stable angina pectoris.

Authors:  U Thadani; R J Lipicky
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.